KEY PRODUCTS
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1Seqens
01 1GRANISETRON BASE
01 1France
01 1Active
01 1Blank
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22311
Submission : 2008-12-15
Status : Active
Type : II
20
Wavelength Enterprises Ltd, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
One of their notable products is GRANISETRON BASE, with a corresponding US DMF Number 22311.
Remarkably, this DMF maintains an Active status since its submission on December 15, 2008, highlighting commitment to regulatory compliance.
